Charles Schwab’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378M | Buy |
|
|||||
|
2025
Q1 | $451M | Buy |
|
|||||
|
2024
Q4 | $496M | Buy |
|
|||||
|
2024
Q3 | $708M | Buy |
|
|||||
|
2024
Q2 | $696M | Buy |
|
|||||
|
2024
Q1 | $614M | Buy |
|
|||||
|
2023
Q4 | $545M | Buy |
|
|||||
|
2023
Q3 | $492M | Sell |
|
|||||
|
2023
Q2 | $431M | Buy |
|
|||||
|
2023
Q1 | $489M | Buy |
|
|||||
|
2022
Q4 | $423M | Buy |
|
|||||
|
2022
Q3 | $395M | Buy |
|
|||||
|
2022
Q2 | $337M | Buy |
|
|||||
|
2022
Q1 | $393M | Buy |
|
|||||
|
2021
Q4 | $351M | Buy |
|
|||||
|
2021
Q3 | $320M | Buy |
|
|||||
|
2021
Q2 | $282M | Buy |
|
|||||
|
2021
Q1 | $236M | Sell |
|
|||||
|
2020
Q4 | $249M | Buy |
|
|||||
|
2020
Q3 | $286M | Buy |
|
|||||
|
2020
Q2 | $294M | Buy |
|
|||||
|
2020
Q1 | $174M | Buy |
|
|||||
|
2019
Q4 | $134M | Sell |
|
|||||
|
2019
Q3 | $103M | Sell |
|
|||||
|
2019
Q2 | $123M | Buy |
|
|||||
|
2019
Q1 | $152M | Buy |
|
|||||
|
2018
Q4 | $111M | Buy |
|
|||||
|
2018
Q3 | $116M | Buy |
|
|||||
|
2018
Q2 | $98.8M | Sell |
|
|||||
|
2018
Q1 | $102M | Buy |
|
|||||
|
2017
Q4 | $107M | Buy |
|
|||||
|
2017
Q3 | $120M | Buy |
|
|||||
|
2017
Q2 | $120M | Buy |
|
|||||
|
2017
Q1 | $89.2M | Buy |
|
|||||
|
2016
Q4 | $79.9M | Buy |
|
|||||
|
2016
Q3 | $83.9M | Sell |
|
|||||
|
2016
Q2 | $73.1M | Buy |
|
|||||
|
2016
Q1 | $74.1M | Sell |
|
|||||
|
2015
Q4 | $118M | Buy |
|
|||||
|
2015
Q3 | $86.9M | Buy |
|
|||||
|
2015
Q2 | $90.6M | Buy |
|
|||||
|
2015
Q1 | $76.6M | Buy |
|
|||||
|
2014
Q4 | $67M | Buy |
|
|||||
|
2014
Q3 | $56.8M | Sell |
|
|||||
|
2014
Q2 | $46.4M | Buy |
|
|||||
|
2014
Q1 | $46.7M | Buy |
|
|||||
|
2013
Q4 | $41.8M | Buy |
|
|||||
|
2013
Q3 | $46.8M | Buy |
|
|||||
|
2013
Q2 | $32M | Buy |
|